|
0
|
|
Safety, Feasibility, and Rifapentine Plasma Concentration in Chinese Children With 1 Month of Daily Rifapentine Plus Isoniazid for Tuberculosis Infection.
(academic.oup.com)
|
Liu W
…
Zhang P
Clinical Infectious Diseases
2026-02-04
|
#pharmacokinetics
#clinical trial
#chemotherapy
#pediatrics
#tb
|
|
0
|
|
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia.
(journals.asm.org)
|
Williamson R
…
Rhodes NJ
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#infection
#amr
|
|
0
|
|
Pharmacokinetics/pharmacodynamics of ceftazidime-avibactam in critically ill adult patients receiving continuous renal replacement therapy.
(journals.asm.org)
|
Li C
…
Ge Y
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#dosing
#amr
#pharmacodynamics
#sepsis
|
|
0
|
|
Evaluation of cerebrospinal fluid penetration of delafloxacin in a murine model.
(journals.asm.org)
|
Lahouati M
…
Xuereb F
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#antibiotic
#meningitis
#penetration
|
|
0
|
|
Monthly dalbavancin dosing for suppressive therapy: a pharmacokinetic estimation analysis and case series.
(journals.asm.org)
|
Kufel WD
…
Volk C
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#infection
#amr
|
|
0
|
|
Pilot phase clinical trial of a wearable, electrochemical aptamer-based patch for continuous drug concentration measurement.
(nature.com)
|
Booth MA
…
Plaxco KW
Nature Biotechnology
2026-02-04
|
#pharmacokinetics
#biosensor
#therapeutic drug monitoring
#precision medicine
#wearable
|
|
0
|
|
Effects of renal impairment and hemodialysis on the pharmacokinetics and safety of HRS-8427, a siderophore cephalosporin for Gram-negative bacterial infections.
(journals.asm.org)
|
Wu Y
…
Zhang J
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#infection
#antibiotic
#renal impairment
#hemodialysis
|
|
0
|
|
First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studies.
(journals.asm.org)
|
Stanley SE
…
Nussbaum J
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#toxicology
#malaria
#clinical trial
|
|
0
|
|
Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).
(journals.asm.org)
|
Bekker A
…
Cressey TR
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#amr
#sepsis
#neonatal
|
|
0
|
|
Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.
(journals.asm.org)
|
Gumbo T
…
Srivastava S
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#amr
#pharmacodynamics
#tb
|
|
0
|
|
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumonia.
(journals.asm.org)
|
Zurawska M
…
Rhodes NJ
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#infection
#amr
#renal
|
|
0
|
|
Population pharmacokinetics of caspofungin in critically ill Chinese children: a prospective observational study.
(journals.asm.org)
|
Xu N
…
Wang Y
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#infection
#pediatric
|